ConductScience.org, home

Paper20041971

FXR an emerging therapeutic target for the treatment of atherosclerosis.

Mencarelli A and 1 other. J Cell Mol Med, 2010. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. FXR an emerging therapeutic target for the treatment of atherosclerosis. Papers, record 20041971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20041971

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FXR an emerging therapeutic target for the treatment of atherosclerosis.
PubMed
Journal
J Cell Mol Med
PubMed
Year
2010
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
1.98
iCite
Revised in PubMed
2026-01-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mencarelli AAndrea
2Fiorucci SStefano

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtherosclerosisMajor topic
Receptors, Cytoplasmic and NuclearMajor topic
Animals
Bile Acids and Salts
Cholesterol
Glucose
Humans
Insulin
Liver
Models, Molecular
Protein Structure, Tertiary
Signal Transduction
Triglycerides
Receptor, Farnesoid X-Activated

Source PubMed

Download CSV of topics

References112

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114664901The DDAH/ADMA/NOS pathway.Atheroscler Suppl2003https://conductscience.org/library/papers/14664901PubMed
219418582Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation.World J Gastroenterol2009https://conductscience.org/library/papers/19418582PubMed
319174369Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice.J Lipid Res2009https://conductscience.org/library/papers/19174369PubMed
412093894Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype.J Clin Invest2002https://conductscience.org/library/papers/12093894PubMed
515337761Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4.J Biol Chem2004https://conductscience.org/library/papers/15337761PubMed
612062084Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis.Dev Cell2002https://conductscience.org/library/papers/12062084PubMed
717065154Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation.J Biol Chem2006https://conductscience.org/library/papers/17065154PubMed
817110163Effects of FXR in foam-cell formation and atherosclerosis development.Biochim Biophys Acta2006https://conductscience.org/library/papers/17110163PubMed
916778009The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.Mol Pharmacol2006https://conductscience.org/library/papers/16778009PubMed
1012524422A G protein-coupled receptor responsive to bile acids.J Biol Chem2003https://conductscience.org/library/papers/12524422PubMed
1117179929Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.Nat Clin Pract Endocrinol Metab2007https://conductscience.org/library/papers/17179929PubMed
1217720959Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.J Lipid Res2007https://conductscience.org/library/papers/17720959PubMed
1317895379Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17895379PubMed
1418249172Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.Cell Metab2008https://conductscience.org/library/papers/18249172PubMed
1516446356The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.J Biol Chem2006https://conductscience.org/library/papers/16446356PubMed
1610334992Identification of a nuclear receptor for bile acids.Science1999https://conductscience.org/library/papers/10334992PubMed
1718514055Upregulation of decorin by FXR in vascular smooth muscle cells.Biochem Biophys Res Commun2008https://conductscience.org/library/papers/18514055PubMed
1816884925Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans.J Struct Biol2006https://conductscience.org/library/papers/16884925PubMed
1918029909Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.Arterioscler Thromb Vasc Biol2007https://conductscience.org/library/papers/18029909PubMed
2014747391Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease.J Am Soc Nephrol2004https://conductscience.org/library/papers/14747391PubMed

See all 112 referencesDownload CSV of references

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
42506440Mitochondrial Dysfunction in Metabolic-Syndrome-Related MASLD/MASH: Metabolic Mechanisms and Therapeutic Perspectives.Metabolites2026https://conductscience.org/library/papers/42506440PubMed
40376981Farnesoid X receptor‑driven metabolic plasticity: Bridging physiological adaptation and malignant transformation in lipid handling (Review).Int J Mol Med2025https://conductscience.org/library/papers/40376981PubMed
38887706Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions.Front Microbiol2024https://conductscience.org/library/papers/38887706PubMed
37815898Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis.Aging Dis2024https://conductscience.org/library/papers/37815898PubMed
37240434Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship.Int J Mol Sci2023https://conductscience.org/library/papers/37240434PubMed
36059946Targeted bile acid profiles reveal the liver injury amelioration of Da-Chai-Hu decoction against ANIT- and BDL-induced cholestasis.Front Pharmacol2022https://conductscience.org/library/papers/36059946PubMed
35898963Functional, Diagnostic and Therapeutic Aspects of Bile.Clin Exp Gastroenterol2022https://conductscience.org/library/papers/35898963PubMed
34831429The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity.Cells2021https://conductscience.org/library/papers/34831429PubMed
33925648In Silico Exploration of the Potential Role of Acetaminophen and Pesticides in the Etiology of Autism Spectrum Disorder.Toxics2021https://conductscience.org/library/papers/33925648PubMed
33521099Overview of bile acid signaling in the cardiovascular system.World J Clin Cases2021https://conductscience.org/library/papers/33521099PubMed
33462736RNA-Seq transcriptome analysis of ileum in Taiping chicken supplemented with the dietary probiotic.Trop Anim Health Prod2021https://conductscience.org/library/papers/33462736PubMed
33093018Effect of Gender and Various Diets on Bile Acid Profile and Related Genes in Mice.Drug Metab Dispos2021https://conductscience.org/library/papers/33093018PubMed
32846898Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells.Int J Mol Sci2020https://conductscience.org/library/papers/32846898PubMed
32477430Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes.Diabetol Metab Syndr2020https://conductscience.org/library/papers/32477430PubMed
32185502Nonalcoholic Fatty Liver Disease.Handb Exp Pharmacol2022https://conductscience.org/library/papers/32185502PubMed
31783529Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far?J Clin Med2019https://conductscience.org/library/papers/31783529PubMed
30559664Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome.Front Pharmacol2018https://conductscience.org/library/papers/30559664PubMed
30360466Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.Molecules2018https://conductscience.org/library/papers/30360466PubMed
29452349Non-genomic effects of nuclear receptors: insights from the anucleate platelet.Cardiovasc Res2018https://conductscience.org/library/papers/29452349PubMed
29325602Bile Acid Metabolism in Liver Pathobiology.Gene Expr2018https://conductscience.org/library/papers/29325602PubMed

See all 37 cited byDownload CSV of cited by

Genes48

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB118647PubTator's text mininghttps://conductscience.org/library/genes/8647NCBI Gene
ABCB45244PubTator's text mininghttps://conductscience.org/library/genes/5244NCBI Gene
ADIPOQ9370PubTator's text mininghttps://conductscience.org/library/genes/9370NCBI Gene
AGTR1185PubTator's text mininghttps://conductscience.org/library/genes/185NCBI Gene
APOA1335PubTator's text mininghttps://conductscience.org/library/genes/335NCBI Gene
APOC3345PubTator's text mininghttps://conductscience.org/library/genes/345NCBI Gene
APOE348PubTator's text mininghttps://conductscience.org/library/genes/348NCBI Gene
CDH111009PubTator's text mininghttps://conductscience.org/library/genes/1009NCBI Gene
COG222796PubTator's text mininghttps://conductscience.org/library/genes/22796NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
CYP7A11581PubTator's text mininghttps://conductscience.org/library/genes/1581NCBI Gene
CYP8B11582PubTator's text mininghttps://conductscience.org/library/genes/1582NCBI Gene
DDAH123576PubTator's text mininghttps://conductscience.org/library/genes/23576NCBI Gene
EDN11906PubTator's text mininghttps://conductscience.org/library/genes/1906NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
FETUB26998PubTator's text mininghttps://conductscience.org/library/genes/26998NCBI Gene
FGF199965PubTator's text mininghttps://conductscience.org/library/genes/9965NCBI Gene
FGFR42264PubTator's text mininghttps://conductscience.org/library/genes/2264NCBI Gene
GPBAR1151306PubTator's text mininghttps://conductscience.org/library/genes/151306NCBI Gene
HNF4A3172PubTator's text mininghttps://conductscience.org/library/genes/3172NCBI Gene

See all 48 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20041971

GET https://conductscience.org/api/papers/v1/20041971/references?page=2